|
|
|
Supreme Court could reveal action on travel ban at any time
U.S. Court News |
2017/06/23 10:01
|
The Supreme Court has almost certainly decided what to do about President Donald Trump's travel ban affecting citizens of six mostly Muslim countries.
The country is waiting for the court to make its decision public about the biggest legal controversy in the first five months of Trump's presidency. The issue has been tied up in the courts since Trump's original order in January sparked widespread protests just days after he took office.
The justices met Thursday morning for their last regularly scheduled private conference in June and probably took a vote about whether to let the Trump administration immediately enforce the ban and hear the administration's appeal of lower court rulings blocking the ban.
The court's decision could come any time and is expected no later than late next week, after which the justices will scatter for speeches, teaching gigs and vacations.
Exactly when could depend on whether there are justices who disagree with the outcome and want to say so publicly. It might take time for such an opinion to be written — and perhaps responded to by someone in the majority.
It takes five votes to reinstate the ban, but only four to set the case for argument. Justice Neil Gorsuch, Trump's nominee who was confirmed in April, is taking part in the highest-profile issue yet in his three months on the court.
The case is at the Supreme Court because two federal appellate courts have ruled against the Trump travel policy, which would impose a 90-day pause in travel from citizens of Iran, Libya, Somalia, Sudan, Syria and Yemen.
The 4th U.S. Circuit Court of Appeals in Richmond, Virginia, said the ban was "rooted in religious animus" toward Muslims and pointed to Trump's campaign promise to impose a ban on Muslims entering the country as well as tweets and remarks he has made since becoming president.
|
|
|
|
|
|
|
High court rejects new trial request in Boston murder case
U.S. Court News |
2017/06/23 10:01
|
The Supreme Court on Thursday ruled against a Boston man seeking to overturn his murder conviction because his lawyer failed to object when the trial judge closed the courtroom during jury selection.
Justice Anthony Kennedy said in the 7-2 ruling that the error Kentel Weaver's lawyer committed did not appear to affect the outcome of the case. Weaver was found guilty in the 2003 murder of a 15-year-old boy.
The lawyer's failure to object prevented Weaver's mother and others from watching what should have been a public jury selection process. The judge had closed the courtroom because it was overcrowded.
Weaver's lawyer later testified that he mistakenly believed closing the court for jury selection was permitted. In fact, it violates the Sixth Amendment right to a public trial.
But Kennedy said Weaver did not show a "reasonable probability of a different outcome but for counsel's failure to object." He said the lawyer's shortcomings did not lead to a "fundamentally unfair trial."
Weaver was only 16 years old at the time of murder. Prosecutors said the victim, Germaine Rucker, was attacked by a group of men and boys after selling some jewelry to a woman, and was shot twice.
Witnesses saw a boy wearing a baseball cap pull a pistol from his pants leg. The cap fell off and was recovered by police, who discovered Weaver's DNA on it. Weaver confessed to his mother, and later, to police when his mother brought him to the police station.
Before trial, the judge ordered the courtroom closed because it was overcrowded with 90 prospective jurors, forcing some to stand in the hallway. Weaver's mother and a friend tried to get in but were refused entry.
|
|
|
|
|
|
|
High Court ruling may hurt claims of talc link to cancer
Legal Line News |
2017/06/22 10:02
|
A Supreme Court ruling this week could have a "chilling effect" on the many lawsuits filed in St. Louis claiming talcum powder causes a deadly form of cancer in women, including cases under appeal in which stricken women and their survivors have been awarded more than $300 million, experts said Tuesday.
Justices ruled 8-1 Monday that hundreds of out-state-residents can't sue Bristol-Myers Squibb Co. in California state court over adverse reactions to the blood thinner Plavix. It followed a similar ruling in May related to out-of-state injury claims against BNSF Railway Co. Both were seen as wins for companies opposed to "venue shopping," in which those filing suit seek out favorable state courts.
Almost immediately after the Supreme Court ruling, St. Louis Circuit Judge Rex Burlison declared a mistrial in a Missouri state court case in which three plaintiffs, two from out-of-state, sued Johnson & Johnson, claiming its talcum powder caused ovarian cancer.
More than 1,000 others have filed similar lawsuits in St. Louis against Johnson & Johnson, but most don't live in Missouri. Five trials have already taken place over the past 16 months. In four of those cases, jurors awarded more than $300 million combined.
Johnson & Johnson believes that the Supreme Court ruling "requires reversal of the talc cases that are currently under appeal in St. Louis," spokeswoman Carol Goodrich said in an email. She said the ruling "makes it clear that Johnson & Johnson was wrongfully forced to defend itself in multiple trials in Missouri, a state with no connection to the plaintiffs."
Jim Onder, whose suburban St. Louis-based law firm is representing many women and survivors who filed suit, said Missouri is a proper venue because Johnson & Johnson, though based in New Jersey, uses a factory in Union, Missouri, to package and label talcum products.
|
|
|
|
|
|
|
EU Court: Vaccines Can Be Blamed for Illnesses Without Proof
Court News |
2017/06/21 10:01
|
The highest court of the European Union ruled Wednesday that courts can consider whether a vaccination led to someone developing an illness even when there is no scientific proof.
The decision was issued on Wednesday in relation to the case of a Frenchman known as Mr. J.W., who was immunized against hepatitis B in late 1998-99. About a year later, Mr. J.W. was diagnosed with multiple sclerosis. In 2006, he and his family sued vaccine-maker Sanofi Pasteur in an attempt to be compensated for the damage they claim he suffered due to the vaccine. Mr. J.W. died in 2011.
France's Court of Appeal ruled there was no causal link between the hepatitis B vaccine and multiple sclerosis, and dismissed the case. Numerous studies have found no relationship between the hepatitis B shot and multiple sclerosis.
After the case went to France's Court of Cassation, it was brought to the European Union. On Wednesday, the EU's top court said that despite the lack of scientific consensus on the issue, a vaccine could be considered defective if there is "specific and consistent evidence," including the time between a vaccine's administration and the occurrence of a disease, the individual's previous state of health, the lack of any family history of the disease and a significant number of reported cases of the disease occurring following vaccination.
In a statement, the court said that such factors could lead a national court to conclude that "the administering of the vaccine is the most plausible explanation" for the disease and that "the vaccine therefore does not offer the safety that one is entitled to expect." It did not rule on the specific French case.
|
|
|
|
|
|
Legal Marketing News RSS
